<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Humans possess two mitochondrial ferredoxins, Fdx1 <br /> and Fdx2, with distinct roles in steroidogenesis, <br /> heme, and Fe/S cluster biosynthesis <br />  <br /> Mammalian adrenodoxin (ferredoxin 1; Fdx1) is essential for the                 its electrons <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> Arh1 (yeast adrenodoxin reductase homologue <br /> synthesis of various steroid hormones in adrenal glands. As a                   1), which uses NADH as an electron source (12&#226;&#8364;&#8220;14). Arh1 and <br /> member of the [2Fe-2S] cluster-containing ferredoxin family, Fdx1               Yah1 function in an early step of Fe/S protein biogenesis, the <br /> reduces mitochondrial cytochrome P450 enzymes, which then                       assembly of a transient Fe/S cluster on the Fe/S scaffold protein <br /> catalyze; e.g., the conversion of cholesterol <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> pregnenolone, aldos-           Isu1. An additional function of mitochondrial Yah1 has been <br /> terone, and cortisol. The high protein sequence similarity between              demonstrated by studies initially carried out in yeast: the forma- <br /> Fdx1 and its yeast adrenodoxin homologue (Yah1) suggested                       tion of the heme A cofactor of cytochrome c oxidase (respiratory <br /> that Fdx1, like Yah1, may be involved in the biosynthesis of heme               complex IV [COX]) (15, 16). In this process, Arh1 and Yah1, <br /> A and Fe/S clusters, two versatile and essential protein cofactors.             together with the heme A synthase Cox15, participate in the <br /> Our study, employing RNAi technology to deplete human Fdx1,                     hydroxylation of heme O to heme A, which is then assembled into <br /> did not confirm this expectation. Instead, we identified a Fdx1-                COX. The ferredoxin electron transfer chains are of considerable <br /> related mitochondrial protein, designated ferredoxin 2 (Fdx2) and               medical importance. A genetic defect in human Cox15 leads to <br /> found it to be essential for heme A and Fe/S protein biosynthesis.              infantile COX deficiency and cardiomyopathy, AdR has been <br /> Unlike Fdx1, Fdx2 was unable to efficiently reduce mitochondrial                shown to act as a tumor suppressor, and defects in CYPs are <br /> cytochromes P450 and convert steroids, indicating that the two                  associated with several diseases (17&#226;&#8364;&#8220;19). <br /> ferredoxin isoforms are highly specific for their substrates in distinct            DNA sequence analysis of the human genome for homologues <br /> biochemical pathways. Moreover, Fdx2 deficiency had a severe                    of yeast Yah1 yields two such genes: FDX1 (chromosome 11q22) <br /> impact, via impaired Fe/S protein biogenesis, on cellular iron home-            and FDX2 (19p13.2; annotated as &#226;&#8364;&#339;Fdx1L&#226;&#8364;&#65533;). Protein sequence <br /> ostasis, leading to increased cellular iron uptake and iron accumula-           alignment reveals that the predicted, mature form of Fdx2 has <br /> tion in mitochondria. We conclude that mammals depend on two                    50% identity and 73% similarity with Yah1, whereas those of <br /> distinct mitochondrial ferredoxins for the specific production of               Fdx1 and Yah1 are 48% and 73%, respectively; Fdx1 and <br /> either steroid hormones or heme A and Fe/S proteins.                            Fdx2 share 43% identity and 69% similarity (cf. ref. 20). It is gen- <br />                                                                                 erally assumed from the high sequence similarity of mammalian <br /> adrenodoxin &#226;&#710;&#163; cytochrome P450 &#226;&#710;&#163; iron &#226;&#710;&#163; iron-sulfur cluster &#226;&#710;&#163; IRP1               adrenodoxin and yeast Yah1 that the former protein is also <br />                                                                                 capable of catalyzing the biosynthesis of Fe/S clusters and heme <br />                                                                                 A (9, 10, 13, 15). In the current study, we tested this assumption <br /> T   he ferredoxin family comprises iron-sulfur (Fe/S) proteins <br />     whose evolutionary debut presumably predates membrane- <br /> bound life (1). Similar to many other Fe/S proteins, ferredoxins <br />                                                                                 for human adrenodoxin (Fdx1). Our results indicate that the <br />                                                                                 expression and function of Fdx1 is largely confined to the adrenal <br /> exploit the redox properties of their [2Fe-2S] or [4Fe-4S] cofac-               gland and has no detectable general role in mammalian Fe/S <br /> tors to transfer electrons in a wide variety of biochemical                     protein biogenesis. Instead, we identify a heretofore uncharacter- <br /> reactions throughout numerous, divergent species. The subfamily                 ized, human [2Fe-2S] cluster ferredoxin (henceforth referred to <br /> of [2Fe-2S] ferredoxins is of bacterial origin, has a molecular mass            as ferredoxin 2; Fdx2). Like Fdx1, Fdx2 is localized to mitochon- <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                    BIOCHEMISTRY <br /> of 6&#226;&#8364;&#8220;25 kDa and is negatively charged at neutral pH. The most                   dria, contains a [2Fe-2S] cluster, and can accept electrons from <br /> well-known eukaryotic members of this subfamily are present in                  NADPH via FdxR. Importantly, Fdx2 is essential for Fe/S protein <br /> plastids of plants or algae and in mitochondria. Various isoforms               biogenesis in human cells and can functionally replace Yah1. <br /> of plant (2) and algal (3) ferredoxins were recently demonstrated               However, unlike Fdx1, Fdx2 is unable to reduce mitochondrial <br /> to perform diverse and highly substrate-specific activities. These              cytochrome P450. Thus, despite their striking sequence similarity, <br /> ferredoxins differ substantially in both protein sequence and                   human Fdx1 and Fdx2 show a remarkable specificity for distinct <br /> function from mitochondrial and bacterial [2Fe-2S] ferredoxins                  biochemical processes. <br /> that are highly related in sequence. In mammalian mitochondria, <br /> adrenodoxin (Adx; herein termed Fdx1) participates in adrenal                   Results <br /> steroidogenesis, bile acid, and vitamin D synthesis (see refs.                  Fdx2 Is a Mitochondrial [2Fe-2S] Protein. To examine whether Fdx2 is <br /> 4&#226;&#8364;&#8220;7 for review). In these biochemical pathways, electrons are                   expressed in human cells and imported into mitochondria, we <br /> transferred from NADPH via Adx reductase (AdR; FdxR) to <br /> Fdx1, which in turn reduces members of the mitochondrial cyto-                  Author contributions: A.D.S., O.S., A.J.P., U.M., F.H., and R.L. designed research; A.D.S., <br /> chrome P450 (CYP) protein family such as P450scc (CYP11A1)                      A.J.P., H.-P.E., U.M., and A.H. performed research; A.D.S., O.S., A.J.P., H.-P.E., U.M., H.W., <br /> and the CYP11B subgroup. The former enzyme catalyzes the                        A.H., F.H., R.B., and R.L. analyzed data; and A.D.S., O.S., A.J.P., H.W., A.H., F.H., R.B., <br /> production of pregnenolone, the rate-limiting step in adrenal                   and R.L. wrote the paper. <br />  <br /> steroid biosynthesis, whereas CYP11B enzymes convert later                      The authors declare no conflict of interest. <br /> intermediates into cortisol, corticosterone, or aldosterone.                    This article is a PNAS Direct Submission. S.M. is a guest editor invited by the Editorial Board. <br />    Bacterial and mitochondrial [2Fe-2S] ferredoxins perform a                   1 <br />                                                                                 To whom correspondence should be addressed. E-mail: lill@staff.uni-marburg.de. <br /> basic biosynthetic function in the maturation of Fe/S proteins                  This article contains supporting information online at www.pnas.org/lookup/suppl/ <br /> (8&#226;&#8364;&#8220;11). The yeast adrenodoxin homologue 1 (Yah1) receives                       doi:10.1073/pnas.1004250107/-/DCSupplemental. <br />  <br />  <br />  <br /> www.pnas.org/cgi/doi/10.1073/pnas.1004250107                                                                   PNAS &#226;&#710;&#163; June 29, 2010 &#226;&#710;&#163; vol. 107 &#226;&#710;&#163; no. 26 &#226;&#710;&#163; 11775&#226;&#8364;&#8220;11780 <br />  raised antibodies against recombinant, His-tagged Fdx2. We then                    We also determined the reduction potentials of Fdx1 and Fdx2 <br /> analyzed subcellular fractions generated from human HeLa cells                     to be &#226;&#710;&#8217;267   5 mV and &#226;&#710;&#8217;342   5 mV, respectively (22). In sum- <br /> by immunoblotting. A protein cofractionating with a mitochon-                      mary, these data indicate that Fdx2 is a mitochondrial [2Fe-2S] <br /> drial marker (&#206;&#177;/&#206;&#178; subunits of F1 -ATPase) and with an apparent                     protein ubiquitously expressed in human tissues. <br /> molecular mass of 22 kDa was recognized by our anti-Fdx2 <br /> antibody (Fig. 1A).                                                                Fdx2, and Not Fdx1, Is a Member of the Mitochondrial Fe/S Protein <br />     To compare the relative expression levels of the two ferredox-                 Assembly Machinery. To investigate the function of Fdx2, the <br /> ins in HeLa cells, we used a dilution series of recombinant                        protein was depleted in HeLa cells using RNAi technology. To <br /> purified proteins for immunoblotting. Fdx1 and Fdx2 were pre-                      this end, cells were transfected with a pool of modified siRNAs <br /> sent in HeLa cells at 90 and 40 ng&#226;&#710;&#8226;mg cell protein, respectively.                  that targeted three distinct regions of the mRNA. The transfec- <br /> We then analyzed the relative abundance of these proteins in                       tions were repeated thrice, once every 3 d, and a final harvest of <br /> various human tissues. Fdx1 protein was undetectable in most                       the cells was performed 3 d after the third transfection (i.e., day 9; <br /> tissue lysates, but was highly expressed in the adrenal gland,                     cf. ref. 23). Fdx1 was analyzed in parallel. Immunoblotting against <br /> and present in kidney and testes (Fig. S1). This expression <span id='am-81' about='xsp:pattern' typeof='owl:Thing'>pattern</span>                Fdx1 or Fdx2 verified an extensive depletion of the individual <br /> fits perfectly with the function of Fdx1 in steroidogenesis, but is                proteins over the course of the experiment (Fig. 2A). <br /> inconsistent with its predicted function in Fe/S protein biogenesis.                   Depletion of Fdx2 by RNAi caused a strong decrease in cell <br /> In contrast, Fdx2 was detectable in virtually all tissues analyzed                 proliferation assigning an important function to Fdx2 in HeLa <br /> with the highest amounts present in testis, kidney, and brain.                     cells (Fig. 2B). In contrast, no significant effect was observed <br />     We next asked whether Fdx2 is an Fe/S protein. Recombinant                     upon Fdx1 depletion. We next performed a series of enzyme <br /> Fdx2 purified from Escherichia coli was red-brown in color and                     assays to evaluate the results of Fdx1 or Fdx2 knockdowns on <br /> exhibited a UV-Vis spectrum characteristic of a [2Fe-2S] protein                   the activities of several Fe/S proteins. As depicted in Fig. 2C, <br /> and remarkably similar to that of purified Fdx1, with an undulat-                  the catalytic activities of mitochondrial and cytosolic aconitases, <br /> ing, reduction-sensitive absorption shoulder between 400 and                       complex I, COX, and succinate dehydrogenase (SDH) relative to <br /> 500 nm (21) (Fig. 1B). The presence of a [2Fe-2S] cluster on                       control proteins were all severely (65&#226;&#8364;&#8220;90%) decreased upon Fdx2 <br /> Fdx2 was supported by EPR spectroscopy of dithionite-reduced                       depletion. This effect escalated with each subsequent transfec- <br /> protein (Fig. 1C). The axial EPR spectra of Fdx1 and Fdx2 had                      tion. In contrast, Fdx1 depletion had no effect on either aconitase <br /> similar g values (2.02, 1.94) and were both detectable up to 80 K.                 isoform or complex I activity, and elicited a relatively weak <br />                                                                                    (10&#226;&#8364;&#8220;30%) diminishment of COX and SDH activities. More cycles <br />                                                                                    of transfection did not augment these effects of Fdx1 deficiency. <br />                                                                                    By transfecting HeLa cells separately with the individual siRNAs <br />                                                                                    against Fdx1, we found that all three individual siRNA sequences <br />                                                                                    elicited the same response as the siRNA pool, suggesting that the <br />                                                                                    slightly dimished activities of COX and SDH were indeed the <br />                                                                                    result of lowered Fdx1 levels. Mitochondria of Fdx2-deficient, <br />                                                                                    but not of Fdx1-deficient cells exhibited a substantial loss of <br />                                                                                    cristae membranes (Fig. S2), consistent with the severe effects <br />                                                                                    on respiratory chain function upon Fdx2 depletion (23, 24). <br />                                                                                        Because Fdx1 and Fdx2 are highly homologous, we investi- <br />                                                                                    gated whether they may have coinciding functions by testing if <br />                                                                                    Fdx1 can replace Fdx2 function. Cells were thrice cotransfected <br />                                                                                    with the Fdx2 siRNAs along with a vector encoding EGFP or the <br />                                                                                    fusion proteins Fdx1-GFP (pFDX1) and Fdx2-GFP (psmFDX2). <br />                                                                                    Silent mutations (sm) were introduced into the latter construct to <br />                                                                                    avoid <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span>RNA interference</span>. The strong effects of Fdx2 depletion on <br />                                                                                    the two aconitases, SDH, COX, complex I, and mitochondrial <br />                                                                                    ultrastructure were almost fully restored by cotransfection with <br />                                                                                    psmFDX2 indicating the specificity of the RNAi approach <br />                                                                                    (Fig. 2D, Fig. S2, and Fig. S3). No restoration of the enzyme <br />                                                                                    activities was seen upon overexpression of Fdx1, indicating that <br />                                                                                    Fdx1 cannot generally assume the role of Fdx2 in Fe/S protein <br />                                                                                    biogenesis. <br />                                                                                        Estimating the protein amounts of several Fe/S proteins is <br />                                                                                    also informative with respect to a cell&#226;&#8364;&#8482;s capacity to form the <br />                                                                                    metallo-cofactor (25, 26). In line with the aforementioned results, <br />                                                                                    the levels of mitochondrial aconitase, cytosolic aconitase (IRP1) <br />                                                                                    and SDH were all decreased under Fdx2 depletion (Fig. 2E). <br /> Fig. 1. Fdx2 is a mitochondrial [2Fe-2S] protein. (A) HeLa cell fractions, total   Again, this defect was restored by cotransfection with psmFDX2, <br /> lysate (L), cytosolic (C), and mitochondria-rich pellet (M), were evaluated by     but not with pFDX1. In addition, an integral subunit (NDUFS3) <br /> immunoblotting using antiserum against Fdx1 or Fdx2 as indicated. Probing          of complex I, which harbors eight Fe/S clusters, ferrochelatase <br /> with antibodies against F1 ATPase &#206;&#177;/&#206;&#178; subunits or tubulin served as controls for   (FC; one [2Fe-2S] cluster) and glutamate phosphoribosylpyropho- <br /> mitochondrial and cytosolic loading, respectively. (B) Recombinant Fdx1 or         sphate amidotransferase (GPAT; one [4Fe-4S] cluster) were all <br /> Fdx2 (10 &#206;&#188;M) were examined by UV-Vis spectroscopy before and after                 specifically diminished by Fdx2 depletion relative to tubulin (load- <br /> reduction by 0.1 &#206;&#188;M AdR&#226;&#710;&#8226;2.5 mM NADPH. (C) EPR spectra (thick lines) and their <br />                                                                                    ing control; Fig. 2E). As an additional strategy to detect alterations <br /> simulations (thin lines) of dithionite-reduced recombinant ferredoxins. EPR <br /> conditions: microwave frequency, 9.458 GHz; microwave power, 0.013 mW; <br />                                                                                    in respiratory complexes, we measured the radiolabelling of these <br /> modulation frequency, 100 kHz; modulation amplitude, 1.25 mT; tempera-             complexes in cells that were treated with 55 Fe-transferrin for the <br /> ture, 10 K. Simulation parameters (gz , gy , gx , and their Gaussian linewidths    3 d following the third transfection. Analysis by blue native-poly- <br /> in mT): Fdx1: [2.0248, 1.9409, 1.9328, 1.08, 1.43, 1.27]; Fdx2: [2.0216,           acrylamide gel electrophoresis (BN-AGE) and autoradiography <br /> 1.9413, 1.9329, 1.12, 1.23, 1.67].                                                 (24, 27) revealed that Fdx2 deficiency led to decreased 55 Fe incor- <br />  <br /> 11776 &#226;&#710;&#163;    www.pnas.org/cgi/doi/10.1073/pnas.1004250107                                                                                      Sheftel et al. <br />  Fig. 2. Fdx2 is an essential component of the Fe/S protein biogenesis pathway in humans. (A) Depletion of the indicated ferredoxins by RNAi was verified <br /> by subjecting total HeLa cell lysates to immunoblotting following each of three sequential transfections with the respective siRNA. CTL, mock transfected cells; <br /> numbers indicate number of transfections. (B) HeLa cell growth after the transfections with Fdx-specific siRNAs (siFDX) was estimated by cell counting, and <br /> normalized to that of mock-transfected cells. (C) Enzyme activities of cell fractions from part B. The values were normalized to citrate synthase (CS) or LDH <br /> activities and displayed as the fraction of the control values for each transfection (dotted line). (D) Cells were cotransfected with the pEGFP-N3 vector (CTL) <br /> alone or together with the Fdx2 siRNA (siFDX2) and pFDX1 (encodes Fdx1-GFP; &#195;&#190;FDX1) or, psmFDX2 (encodes Fdx2-GFP and contains silent mutations <br /> conferring RNAi avoidance; &#195;&#190;smFDX2). Enzyme assays were performed as in (C) using the triply transfected samples. (E) Immunoblots from cells transfected <br /> as in part D, using the indicated antibodies. mAco, mitochondrial aconitase; NDUFS3, subunit of complex I; FC, ferrochelatase; GPAT, glutamate phosphor- <br /> ibosylpyrophosphate amidotransferase; IRP1, iron regulatory protein 1; Tub, tubulin. (F) Cells were transfected as in (D), and treated with 0.5 &#206;&#188;M 55 Fe-trans- <br /> ferrin after the third transfection. Crude mitochondrial fractions were subjected to blue-native PAGE, followed by phosphorimaging. (G) Densitometric analysis <br /> of the complexes I (CI) and II (CII) bands from three independent experiments as in part F. Error bars represent standard deviations. <br />  <br />  <br /> poration into complexes I and II, which was restored by expression                by measuring the activity of the heme-dependent catalase. Third, <br /> from plasmid psmFDX2 but not pFDX1 (Fig. 2F). The lack of an                      the severe defect in COX activity in Yah1-depleted Gal-YAH1 <br /> effect on complex III may be explained by dissociation of the                     cells (15) was fully rescued by synthesis of Fdx2, indicating that <br /> supercomplex of complexes I, III, and COX upon diminishment                       human Fdx2 can participate not only in yeast mitochondrial Fe/S <br /> of complex I (24) and the fact that half of the iron present in CIII              cluster synthesis but also replace Yah1 function in the hydroxyla- <br /> is in heme. Taken together, the data presented in Fig. 2 strongly                 tion of heme O to heme A. Finally, we tested whether expression <br /> suggest a major role of Fdx2, but not of Fdx1, in Fe/S protein                    of Fdx2 can normalize the activation of the yeast iron regulon <br /> biogenesis.                                                                       observed upon functional defects of the mitochondrial iron-sulfur <br />                                                                                   cluster (ISC) assembly and export machineries (31, 32). As a <br /> Human Fdx2 Can Perform the Biochemical Functions of Yeast Yah1. We                reporter we used the promoter of FET3, which encodes the mul- <br /> asked whether human Fdx2 can functionally replace yeast Yah1 in <br />  <br />  <br />  <br />  <br />                                                                                                                                                                    BIOCHEMISTRY <br />                                                                                   ti-copper ferroxidase of the high affinity iron uptake system (33), <br /> its tasks in Fe/S protein and heme A biosynthesis. We used a yeast                fused to GFP. Green fluorescence was strongly increased in Yah1- <br /> strain (Gal-YAH1), in which a GAL1-10 promoter has been                           depleted Gal-YAH1 cells carrying the FET3-GFP construct <br /> inserted upstream of the YAH1 coding region, thus permitting                      (Fig. 3C) (32). Ectopic expression of human Fdx2 in these cells <br /> regulated expression of the YAH1 gene (12). Gal-YAH1 cells                        normalized the GFP fluorescence to wild-type levels. For all these <br /> grow at wild-type rates in galactose-containing media, yet exhibit                four assay systems, no changes of signals measured for Yah1- <br /> a severe growth defect upon substituting glucose or glycerol for                  deficient cells were observed upon expression of Fdx1 (Fig. 3C). <br /> galactose. Expression and localization of the human ferredoxins,                  Taken together, Fdx2, but not Fdx1 can fully replace yeast Yah1 in <br /> to which fungal mitochondrial targeting sequences were fused,                     all tested biochemical parameters, making Fdx2 the <br /> was verified by immunoblotting (Fig. 3A). Human Fdx2 was able                     functional Yah1 orthologue. <br /> to restore growth of Gal-YAH1 cells on media containing either <br /> glucose or the nonfermentable carbon source glycerol (Fig. 3B).                   Fdx2 Depletion Adversely Affects Cellular Iron Metabolism in Human <br /> Consistent with a previous study, Fdx1 expression failed to                       Cells. Iron regulatory protein 1 (IRP1) is a [4Fe-4S] protein that <br /> replace Yah1 (28).                                                                resides in the cytosol where it has aconitase activity (see Fig. 2). <br />     To analyze if Fdx2 can replace all functions of Yah1, we                      When cellular Fe/S cluster assembly becomes limiting <br /> analyzed several biochemical parameters associated with func-                     (e.g., due to low iron availability or upon defects of the biogenesis <br /> tional loss of Yah1, including defective Fe/S protein biogenesis,                 machineries), IRP1 loses its Fe/S cluster thereby gaining the <br /> heme biosynthesis, and iron regulation (29, 30). First, expression                ability to bind to stem-loop structures of mRNAs encoding <br /> of Fdx2 restored the activity of the Fe/S protein aconitase to the                several proteins involved in iron homeostasis (9, 34). IRP1 func- <br /> same levels as yeast Yah1 (Fig. 3C). Second, Fdx2 was able to                     tions together with the related IRP2 that does not bind an Fe/S <br /> complement the defect in heme synthesis (29, 30), as indicated                    cluster, yet is degraded under iron-replete conditions. Examples <br />  <br /> Sheftel et al.                                                                                         PNAS &#226;&#710;&#163;    June 29, 2010 &#226;&#710;&#163;   vol. 107 &#226;&#710;&#163;   no. 26 &#226;&#710;&#163;   11777 <br />  Fig. 3. Fdx2, but not Fdx1, is a functional orthologue of yeast Yah1. <br /> Gal-YAH1 yeast cells were transformed with either the empty vector                 Fig. 4. Fdx2 depletion affects cellular iron metabolism. (A) Lysates from <br /> p426-TDH3 (-), p426-YAH1-HA, p426-F1&#206;&#178;-Fdx1, or p426-F1&#206;&#178;-Fdx2. The latter           HeLa cells transfected as in Fig. 2C were analyzed for IRP binding activities <br /> plasmids encode either mature Fdx1 or Fdx2, N-terminally fused to the              by electrophoretic mobility shift assay. Because human IRP1 and IRP2 have <br /> mitochondrial presequence of ATPase subunit F1 &#206;&#178; from Neurospora crassa            the same mobility, anti-IRP1 or anti-IRP2 antibodies were used to supershift <br /> under the control of the TDH3 promoter. Cells were cultivated for 40 h in          the respective proteins (the top panel shows IRP1 activity, with IRP2 <br /> synthetic complete minimal medium supplemented with glucose (SD) to                supershifted out of the displayed image). Lysates were treated with 2% <br /> deplete Gal-YAH1 cells for Yah1. (A) Mitochondria (Mit) and postmitochon-          &#206;&#178;-mercaptoethanol (&#206;&#178;-ME) to divulge total IRP1 protein levels. Values indicate <br /> drial supernatants (PMS) were isolated and analyzed for Fdx1 and Fdx2 by           densitometric evaluation of the bands. (B) Total lysates from cells transfected <br /> immunostaining. Porin (Por1) served as a mitochondrial marker. (B) Serial          as in Fig. 2C were subjected to immunoblotting using the indicated antibo- <br /> dilutions of yeast cells were spotted onto agar plates containing SD medium,       dies. TfR, transferrin receptor; Ft, ferritin; Tub, tubulin. (C) Cells were <br /> or rich YP medium supplemented with either glycerol (YPGly) or galactose           transfected as in Fig. 2C, treated with 0.5 &#206;&#188;M 55 Fe-transferrin after the third <br /> (YPGal) and incubated for 3 days at 30 &#194;&#176;C. (C) Activities of aconitase, catalase   transfection, and fractionated. Cytosol (Cyto) crude mitochondria (Crude <br /> and cytochrome oxidase (COX) were determined in extracts prepared from             mito) and total lysates (Lysate) were subjected to native-PAGE to resolve <br /> cells described in part B. Cells of part B were transformed with the reporter      iron-containing proteins from low-molecular mass (Mr ) iron compounds, <br /> construct p414-FET3-GFP that encodes GFP under the control of the promoter         and analyzed by autoradiography. <br /> of FET3, an iron-responsive gene. FET3 promoter activities were assessed by <br /> determining the GFP-specific fluorescence of cells after cultivation in SD <br /> medium for 40 h (lower right). Error bars represent standard deviations. <br />                                                                                    when Fe/S protein biogenesis is hindered (Fig. 4C). The low <br />                                                                                    molecular mass iron species was not detectable in the cytosolic <br />                                                                                    fraction, yet the amount of iron stored in ferritin was decreased. <br /> of IRP-regulated mRNAs are those of transferrin receptor (TfR), <br />                                                                                    We conclude from these data that depletion of mitochondrial Fdx2 <br /> which is stabilized by IRP binding, and ferritin (Ft), whose transla- <br />                                                                                    has a severe effect on cellular iron homeostasis, which is most <br /> tion is inhibited by IRP binding. Because Ft is a ubiquitous iron <br /> storage protein and TfR is the gateway of iron entry into most cells,              likely initiated by an assembly defect of the Fe/S cluster of IRP1. <br /> the reciprocal regulation of these two proteins by iron or Fe/S <br />                                                                                    Fdx2 Cannot Substitute for Fdx1 in Steroidogenesis. Our results so <br /> protein biogenesis endows cells with the ability to rapidly adjust <br />                                                                                    far indicate that Fdx2 performs a specific function in cellular <br /> iron availability to meet cellular needs. In an RNA electrophoretic <br /> mobility shift assay, Fdx2-depleted HeLa cells exhibited a robust                  Fe/S protein assembly. Because this protein is highly homologous <br /> increase in IRP1 RNA binding activity compared to controls or                      to Fdx1, we examined whether it can also participate in the <br /> cells cotransfected with psmFDX2 (Fig. 4A). IRP2 also showed                       reduction of mitochondrial CYP for steroidogenesis. An electron <br /> increased mRNA binding activity. Surprisingly, the changes in                      transfer system was set up in vitro, using NADPH as an electron <br /> the protein levels of the two IRPs were opposite under Fdx2                        source, recombinant purified FdxR, Fdx1, Fdx2, and 11beta- <br /> depletion (Fig. 4B). For IRP1 the decrease is readily explained                    hydroxylase (CYP11B1), and 11-deoxycortisol as the substrate <br /> by the common observation that apo-IRP1 lacking its Fe/S cluster                   (Fig. 5A). Using HPLC, we observed an efficient conversion of <br /> is more prone to degradation (26, 35). Because IRP2 protein                        11-deoxycortisol into cortisol by CYP11B1 that was dependent <br /> levels are negatively regulated by the iron availability in the cytosol            on the Fdx1 concentration (Fig. 5B, Upper). Surprisingly, Fdx2 <br /> (34), our results suggest that cytosolic iron was diminished. To                   was highly inefficient in this reaction; even at 20 &#206;&#188;M Fdx2 barely <br /> verify this, we radiolabeled Fdx2-depleted HeLa cells with                         any product formation was detected (Lower). Quantitative <br /> 55                                                                                 analysis revealed a 500-fold lower rate of conversion by Fdx2 <br />    Fe-transferrin for 3 d, performed cell fractionation, and evalu- <br /> ated the distribution of 55 Fe by native PAGE. A low molecular                     compared to Fdx1 (Inset). UV-Vis spectrophotometry confirmed <br /> mass iron species (36, 37) was dramatically increased in the crude                 that NADPH/FdxR almost instantly reduced the [2Fe-2S] cluster <br /> mitochondrial fraction of cells deficient in Fdx2, suggesting mito-                of Fdx2, indicating that this part of the electron transfer chain <br /> chondrial iron accumulation when Fdx2 is depleted and hence                        does not throttle back the CYP11B1 activity (compare to Fig. 1B). <br />  <br /> 11778 &#226;&#710;&#163;    www.pnas.org/cgi/doi/10.1073/pnas.1004250107                                                                                               Sheftel et al. <br />                                                                                     mammalian Fdx1 has already been resolved (38) and the high <br />                                                                                    level of sequence similarity between Fdx1 and Fdx2 predicts <br />                                                                                    similar structures. Comparative analysis of the primary structures <br />                                                                                    of Fdx1 and Fdx2/Yah1 and the eventual determination of the 3D <br />                                                                                    structure of Fdx2 will make it possible to understand what <br />                                                                                    bestows these ferredoxins with the capacity to interact with <br />                                                                                    specific substrates only. Future study is also needed to determine <br />                                                                                    whether Fdx2 may participate in coenzyme Q synthesis, as has <br />                                                                                    recently been shown for yeast Yah1 (39). <br />                                                                                       The participation of Fdx2 in two fundamental biosynthetic <br />                                                                                    processes explains well why this protein is present in virtually <br />                                                                                    all tissues. It is surprising that, even in excess, the highly similar <br />                                                                                    Fdx1 cannot take over these functions in human or yeast cells. <br />                                                                                    Conversely, our biochemical studies show that Fdx2 is unlikely <br />                                                                                    to participate in mammalian steroidogenesis. Hence, the two <br />                                                                                    ferredoxins serve as specificity devices for electron transfer from <br />                                                                                    a single donor, the ferredoxin reductase (FdxR), to several <br />                                                                                    different target proteins. Whereas the electron-receiving partners <br />                                                                                    of Fdx1 are six well-known mitochondrial CYPs, the details of the <br />                                                                                    electron transfer reaction for Fdx2/Yah1 are only partially under- <br />                                                                                    stood to date. Fdx2/Yah1 may directly interact with Cox15 for the <br />                                                                                    conversion of heme O to heme A, even though this interaction <br /> Fig. 5. Fdx1, but not Fdx2, efficiently transfers electrons for steroidogenesis.   remains to be verified (15). Also, it has been speculated that a <br /> (A) A schematic diagram illustrating the electron transfer from NADPH to           Fdx-mediated electron transfer might be needed for conversion <br /> 11-deoxycortisol catalyzed by FdxR, Fdx1, and CYP. (B) The indicated concen-       of the sulfur of cysteine (formally S0 ) to the sulfide (S2&#226;&#710;&#8217; ) present <br /> trations of recombinant Fdx1 (Upper) or Fdx2 (Lower) were incubated for <br />                                                                                    in Fe/S clusters. This idea is consistent with the fact that Yah1 was <br /> 30 min with recombinant FdxR, mitochondrial cytochrome P450 (CYP11B1), <br /> 11-deoxycortisol, and a NADPH-regenerating system. The steroid compounds <br />                                                                                    shown to act early in Fe/S protein biosynthesis; i.e., for synthesis <br /> were organically extracted and analyzed by HPLC. The inset in the lower            of a nascent Fe/S cluster on the scaffold protein Isu1 (10). <br /> panel depicts a magnification of cortisol formation by Fdx2.                          Unlike in humans, Saccharomyces cerevisiae FC does not con- <br />                                                                                    tain an Fe/S cluster, though blockage in Fe/S protein biogenesis in <br /> Taken together, our findings show a high specificity of Fdx1                       both species results in decreased heme production (30, 40). Given <br /> for steroidogenesis and of Fdx2 for heme A and Fe/S cluster                        the intimate connection between the two major iron-utilizing <br /> biosynthesis.                                                                      pathways, heme and Fe/S cluster biosynthesis, it is not surprising <br />                                                                                    that cellular iron metabolism is directly regulated by the cell&#226;&#8364;&#8482;s <br /> Discussion                                                                         capacity to generate Fe/S clusters (40). In humans, IRP1 is a <br /> Our study demonstrates that humans possess two functionally                        major coupler of these two processes, because the [4Fe-4S] clus- <br /> independent mitochondrial [2Fe-2S] ferredoxins. Despite their                      ter status of this protein dictates its ability to control cellular iron <br /> high sequence similarity these proteins assume highly specific                     homeostasis. Consistent with our finding that Fdx2 is required for <br /> roles in distinct biochemical pathways (Fig. 6). Adrenodoxin                       Fe/S cluster assembly on IRP1 we report disturbed iron distribu- <br /> (Fdx1) can only reduce mitochondrial CYP enzymes that are                          tion in Fdx2-depleted cells. This is reflected by elevated TfR <br /> essential in adrenal steroidogenesis, bile acid formation, and                     levels, suggesting an increase in cellular iron uptake, and by a <br /> vitamin D synthesis (6). The newly characterized Fdx2 specifically                 concomitant drop in Ft levels (9, 23). However, the fate of <br /> participates in both heme A and Fe/S protein biosynthesis, as                      this excess cellular iron that cannot efficiently be stored in Ft <br /> shown by RNAi depletion in human cells and by yeast comple-                        has remained unknown. A similar scenario arises in patients with <br /> mentation experiments, which thus establish Fdx2 as the func-                      Friedreich&#226;&#8364;&#8482;s ataxia, in whom a deficiency in mitochondrial fratax- <br /> tional orthologue of Yah1. A phylogenetic analysis has defined                     in results in decreased Fe/S proteins (41). In these patients, as <br /> two subgroups of mitochondrial ferredoxins with Fdx1/Yah1                          well as in mouse models of the disease (42), it has been suggested <br />  <br />  <br />  <br />  <br />                                                                                                                                                                     BIOCHEMISTRY <br /> in one and Fdx2 in the other subgroup (20). Our investigation                      that iron is accumulating in mitochondria. In yeast, the massive <br /> demonstrates that this subgroup distinction is not reflected in                    mitochondrial iron accumulation under compromised Fe/S <br /> the function of the subgroup members. It will therefore be inter-                  biogenesis is well established (40). Our study directly demon- <br /> esting to unravel what structural features determine the striking                  strates mitochondrial accumulation of a low molecular mass form <br />                                                                                    of iron in an acute model of defective human Fe/S protein bio- <br /> functional specificity of Fdx1 and Fdx2. The 3D structure of <br />                                                                                    genesis (36). <br />                                                                                       In summary, humans depend on two functionally noninterch- <br />                                                                                    angeable mitochondrial ferredoxins, which participate in <br />                                                                                    fundamental physiological processes. Conspicuously, the newly <br />                                                                                    characterized Fdx2 not only transfers electrons for the biogenesis <br />                                                                                    of mitochondrial heme A and Fe/S clusters, but is also essential <br />                                                                                    for the maturation of cytosolic Fe/S proteins, underscoring the <br />                                                                                    importance of mitochondria in all Fe/S protein production in <br />                                                                                    the eukaryotic cell. <br />  <br />                                                                                    Materials and Methods <br />                                                                                    Reagents and Cell Lines. Antibodies against Fdx1 and Fdx2 were raised in <br />                                                                                    rabbits using purified proteins produced in E. coli. The remaining antibodies <br /> Fig. 6. The two mitochondrial [2Fe-2S] ferredoxins fulfill three distinct roles    were against: mitochondrial aconitase (L. Szweda), GPAT (H. Puccio), F1 &#206;&#177;&#226;&#710;&#8226;&#206;&#178; <br /> in mammalian cells. Fdx1 (adrenodoxin) specifically catalyzes reactions            (H. Sch&#195;&#164;gger), TfR (Zymed), Ft (ICN), tubulin (clone DM1&#206;&#177;, Sigma), SDH, <br /> central to steroidogenesis (I), whereas Fdx2 is involved in heme A formation       and NDUFS3 (MitoScience). Small interfering RNAs (siRNAs) with predesigned <br /> and Fe/S protein biogenesis (II and III).                                          sequences were purchased from Applied Biosciences. For all RNAi assays <br />  <br />  <br /> Sheftel et al.                                                                                          PNAS &#226;&#710;&#163;    June 29, 2010 &#226;&#710;&#163;   vol. 107 &#226;&#710;&#163;   no. 26 &#226;&#710;&#163;   11779 <br />  performed, transfection with two separate scrambled siRNAs yielded identi-                      siRNAs, using previously described methods (43) to introduce numerous silent <br /> cal results as mock transfections. Human tissue lysates were purchased from                     mutations (psmFDX2). <br /> Axxora, cell culture reagents from PAA Laboratories, and all other reagents <br /> from Carl Roth GmbH, unless otherwise noted.                                                    Miscellaneous Procedures. Previously described methods were used for <br />     HeLa cells were maintained in DMEM containing 4.5 g&#226;&#710;&#8226;liter glucose and                       harvesting and fractionating HeLa cells with digitonin, transfection by <br /> supplemented with 7.5% FCS, 1 mM glutamine, and 1% penicillin-streptomy-                        electroporation; measurements of the catalytic activities of the aconitases, <br /> cin. The previously described Gal-YAH1 yeast strain was generated in a                          complex I, SDH, cytochrome oxidase, CS and lactate dehydrogenase (LDH), <br /> W303-1A (MAT&#206;&#177;, ura3-1, ade2-1, trp1-1, his3-11,15, leu2-3,112) background                       yeast aconitase, and catalase (27, 44), estimation of yeast iron regulon <br /> by exchanging the YAH1 promoter with a galactose-inducible GAL1-10                              activation by FET3-GFP (30), in vitro hydroxylation of 11-deoxycortisol to <br /> promoter (12).                                                                                  cortisol (19), determination of IRP binding activities (23), native PAGE separa- <br />                                                                                                 tion of iron-bound moieties (36), and iron incorporation into respiratory <br /> Plasmids. All oligonucleotides used, including siRNA sequences, are listed in                   complexes (24, 27). All bar graphs represent the average of at least three <br /> Table S1. Human Fdx1 and Fdx2 cDNA clones in pCMV-SPORT6 were acquired                          independent sets of transfections. <br /> from imaGenes. Using these clones, we performed PCR amplification to clone <br /> the genes lacking their putative mitochondrial targeting sequences into <br /> pETDuet-1 (Novagen), which was then transformed into BL21 E. coli cells                       <br /> for recombinant ferredoxin production. This construct incorporates an <br />                                                                                                 <br /> N-terminal 6xHis tag, which was used for protein purification on a Ni-nitrilo-     <br /> triacetic acid (NTA) column (GE Healthcare Life Sciences). Additional plasmids                  <br /> were generated by cloning the entire coding regions of the respective genes                     <br /> into pEGFP-N3 (Clontech), thus generating constructs that encode Fdx1 (plas-                    <br /> mid pFDX1) or Fdx2 (pFDX2) fused to a C-terminal EGFP. For complementa-                        <br /> tion experiments, pFDX2 was mutated in the coding regions targeted by the                    <br /> </body></html>